South Texas Money Management’s Bristol-Myers Squibb BMY Stock Holding History

South Texas Money Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$266K	Sell	5,248 -2,046	-28%	-$96.2K	0.01%	327
2019 Q2	$331K	Sell	7,294 -3,932	-35%	-$183K	0.01%	171
2019 Q1	$536K	Sell	11,226 -139,337	-93%	-$6.94M	0.02%	140
2018 Q4	$7.83M	Sell	150,563 -498,069	-77%	-$26.8M	0.37%	56
2018 Q3	$40.3M	Sell	648,632 -31,692	-5%	-$1.88M	1.7%	18
2018 Q2	$37.6M	Sell	680,324 -1,642	-0.2%	-$88.7K	1.64%	19
2018 Q1	$43.1M	Buy	681,966 +1,512	+0.2%	+$97.3K	1.98%	12
2017 Q4	$41.7M	Buy	680,454 +6,334	+0.9%	+$396K	1.94%	15
2017 Q3	$43M	Sell	674,120 -3,263	-0.5%	-$191K	2.04%	13
2017 Q2	$37.7M	Sell	677,383 -343	-0.1%	-$18.7K	1.85%	14
2017 Q1	$36.9M	Sell	677,726 -7,083	-1%	-$388K	1.85%	15
2016 Q4	$40M	Buy	684,809 +9,600	+1%	+$525K	2.1%	12
2016 Q3	$36.4M	Sell	675,209 -4,048	-0.6%	-$260K	2.02%	9
2016 Q2	$50M	Sell	679,257 -6,605	-1%	-$467K	2.81%	3
2016 Q1	$43.8M	Buy	685,862 +4,406	+0.6%	+$278K	2.49%	5
2015 Q4	$46.9M	Buy	681,456 +8,323	+1%	+$550K	2.68%	4
2015 Q3	$39.8M	Buy	673,133 +5,168	+0.8%	+$328K	2.41%	5
2015 Q2	$44.4M	Buy	667,965 +8,694	+1%	+$573K	2.57%	4
2015 Q1	$42.5M	Buy	659,271 +13,027	+2%	+$816K	2.46%	5
2014 Q4	$38.1M	Buy	646,244 +5,630	+0.9%	+$318K	2.33%	5
2014 Q3	$32.8M	Buy	640,614 +33,372	+5%	+$1.67M	2.12%	5
2014 Q2	$29.5M	Buy	607,242 +11,439	+2%	+$564K	1.88%	15
2014 Q1	$31M	Buy	595,803 +16,748	+3%	+$891K	2.07%	10
2013 Q4	$30.8M	Buy	579,055 +19,055	+3%	+$971K	2.15%	10
2013 Q3	$25.9M	Buy	560,000 +6,959	+1%	+$305K	2.01%	13
2013 Q2	$24.7M	Buy	+553,041	New	+$24M	2.01%	14

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

South Texas Money Management's BMY Position: Q3 2019 in Review

South Texas Money Management reduced its Bristol-Myers Squibb (BMY) stake by 28% in Q3 2019, selling an estimated $96.2K and leaving 5,248 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #327.

South Texas Money Management first reported a position in BMY in Q2 2013 and has held it in 26 quarters since. The position peaked at $50M in Q2 2016. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

South Texas Money Management held 5,248 shares of Bristol-Myers Squibb worth $266K as of Q3 2019.
South Texas Money Management sold 2,046 Bristol-Myers Squibb shares in Q3 2019, an estimated $96.2K.
Bristol-Myers Squibb made up 0.01% of South Texas Money Management's portfolio in Q3 2019, its #327 holding.
South Texas Money Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 26 quarters since.
South Texas Money Management's Bristol-Myers Squibb position peaked at $50M in Q2 2016.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on South Texas Money Management's 13F filing for Q3 2019, filed 13 Nov 2019.